Eco Animal Health Group (STU:LWA) Tax Provision : €-0.86 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Eco Animal Health Group Tax Provision?

Eco Animal Health Group's tax provision for the six months ended in Sep. 2024 was €-0.41 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.86 Mil.

Eco Animal Health Group Tax Provision Historical Data

The historical data trend for Eco Animal Health Group's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eco Animal Health Group Tax Provision Chart

Eco Animal Health Group Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Tax Provision

Get a 7-Day Free Trial

-0.74

-4.06

-2.51

-1.53

-1.13

Eco Animal Health Group Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Tax Provision	Get a 7-Day Free Trial															-1.06	-0.48	-0.67	-0.45	-0.41

Eco Animal Health Group Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.86 Mil.

Eco Animal Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eco Animal Health Group PLC (STU:LWA) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

EAH:UK LWA:Germany

Address

100 High street, The Grange, Southgate, London, GBR, N14 6BN

Website

https://www.ecoanimalhealth.com

Eco Animal Health Group PLC is engaged in manufacturing and marketing animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The company's geographical segments include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World. Maximum revenue for the company is generated from China and Japan.

Eco Animal Health Group Headlines

No Headlines